海昇药业
(920656)
| 流通市值：5.34亿 | | | 总市值：16.48亿 |
| 流通股本：3237.63万 | | | 总股本：1.00亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 436,052,547.46 | 380,610,266.95 | 57,685,701.55 | 254,019,438.89 |
| 交易性金融资产 | - | 55,216,333 | 360,000,000 | 155,000,000 |
| 应收票据及应收账款 | 33,174,020.65 | 26,310,111.99 | 36,290,427.56 | 34,678,009.3 |
| 应收账款 | 33,174,020.65 | 26,310,111.99 | 36,290,427.56 | 34,678,009.3 |
| 应收款项融资 | 17,861,503.2 | 5,546,649.25 | 5,130,185.33 | 9,474,522.88 |
| 预付款项 | 560,240.5 | 1,596,687.51 | 1,424,056.27 | 1,419,809.21 |
| 其他应收款合计 | 192,000.35 | 211,516.15 | 237,092.44 | 245,901.04 |
| 存货 | 33,098,696.68 | 33,872,013.65 | 27,414,684.07 | 29,200,763.78 |
| 其他流动资产 | - | 428,340.07 | 624,274.79 | 1,726,108.98 |
| 流动资产合计 | 520,939,008.84 | 503,791,918.57 | 488,806,422.01 | 485,764,554.08 |
| 非流动资产: | | | | |
| 固定资产 | 125,781,987.67 | 130,022,429.03 | 124,679,947.33 | 127,690,077.56 |
| 在建工程 | 79,448,156.17 | 78,785,754.69 | 67,491,569 | 50,572,921.47 |
| 无形资产 | 21,528,121.89 | 21,736,024.47 | 21,943,927.05 | 22,151,829.63 |
| 长期待摊费用 | 107,783.4 | 151,895.91 | 196,008.42 | 240,120.93 |
| 递延所得税资产 | 1,174,493.43 | 1,126,934.43 | 386,045.52 | 381,607.94 |
| 其他非流动资产 | 1,408,026.23 | 1,261,088.86 | 2,208,836.98 | 3,528,413.98 |
| 非流动资产合计 | 229,448,568.79 | 233,084,127.39 | 216,906,334.3 | 204,564,971.51 |
| 资产总计 | 750,387,577.63 | 736,876,045.96 | 705,712,756.31 | 690,329,525.59 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 13,499,550.4 | 19,089,457.35 | 8,231,684.86 | 10,045,296.37 |
| 应付账款 | 13,499,550.4 | 19,089,457.35 | 8,231,684.86 | 10,045,296.37 |
| 合同负债 | 55,135.19 | 1,050,524.41 | 1,520,538.57 | 53,483.19 |
| 应付职工薪酬 | - | - | 22,157.55 | 16,584.56 |
| 应交税费 | 5,699,723.95 | 5,651,033.67 | 4,976,582.83 | 4,295,796.37 |
| 其他应付款合计 | 2,064,800 | 2,089,906.44 | 2,133,133.71 | 12,029,438.46 |
| 其他流动负债 | 10,870.34 | 95,404.12 | 348,612.62 | 56,324.44 |
| 流动负债合计 | 21,330,079.88 | 27,976,325.99 | 17,232,710.14 | 26,496,923.39 |
| 非流动负债: | | | | |
| 递延收益 | 5,277,618.23 | 5,455,173.45 | 5,781,310.25 | 196,550.56 |
| 非流动负债合计 | 5,277,618.23 | 5,455,173.45 | 5,781,310.25 | 196,550.56 |
| 负债合计 | 26,607,698.11 | 33,431,499.44 | 23,014,020.39 | 26,693,473.95 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 |
| 资本公积 | 325,885,657.75 | 325,838,558.35 | 325,501,556.02 | 325,164,553.7 |
| 专项储备 | 199,720.37 | 3,966.73 | 4,785.28 | 553.04 |
| 盈余公积 | 48,372,632.75 | 48,372,632.75 | 41,426,934.4 | 41,426,934.4 |
| 未分配利润 | 249,321,868.65 | 229,229,388.69 | 215,765,460.22 | 197,044,010.5 |
| 归属于母公司股东权益合计 | 723,779,879.52 | 703,444,546.52 | 682,698,735.92 | 663,636,051.64 |
| 股东权益合计 | 723,779,879.52 | 703,444,546.52 | 682,698,735.92 | 663,636,051.64 |
| 负债和股东权益合计 | 750,387,577.63 | 736,876,045.96 | 705,712,756.31 | 690,329,525.59 |
| 公告日期 | 2026-04-16 | 2026-04-16 | 2025-10-27 | 2025-08-21 |
| 审计意见(境内) | | 标准无保留意见 | | |